A Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Hypercholesterolemic Patients With Diabetes Mellitus or Metabolic Syndrome
Phase of Trial: Phase IV
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 07 Mar 2008 Status changed from in progress to completed.
- 05 Dec 2007 Status changed from recruiting to in progress.
- 09 Nov 2005 New trial record.